Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Clinical trial NCT06764160 · COMPLETED

Trial details

NCT number: NCT06764160
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis (gMG)Refractory gMG

Start date: 2025-01-06
Primary completion: 2025-12-29
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.